| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis E virus | 4 | 2019 | 306 | 2.24 | Why? |
| Hepatitis E | 4 | 2019 | 319 | 2.12 | Why? |
| Luminescent Measurements | 3 | 2017 | 924 | 1.38 | Why? |
| Hepatitis Antibodies | 2 | 2019 | 100 | 1.37 | Why? |
| Adenoviruses, Human | 2 | 2017 | 195 | 1.17 | Why? |
| Neutralization Tests | 9 | 2021 | 6698 | 1.07 | Why? |
| Influenza A Virus, H7N9 Subtype | 2 | 2019 | 415 | 1.05 | Why? |
| Antibodies, Neutralizing | 25 | 2021 | 25288 | 0.99 | Why? |
| Gene Knock-In Techniques | 2 | 2020 | 124 | 0.95 | Why? |
| Lens Plant | 1 | 2021 | 20 | 0.95 | Why? |
| Abattoirs | 2 | 2019 | 94 | 0.93 | Why? |
| Drug Carriers | 2 | 2017 | 590 | 0.87 | Why? |
| Plant Lectins | 1 | 2021 | 114 | 0.86 | Why? |
| Genetic Techniques | 1 | 2020 | 79 | 0.84 | Why? |
| Whole Body Imaging | 2 | 2017 | 116 | 0.82 | Why? |
| Disease Models, Animal | 9 | 2021 | 10998 | 0.82 | Why? |
| Genetic Vectors | 5 | 2021 | 1600 | 0.74 | Why? |
| Viral Envelope Proteins | 4 | 2020 | 3539 | 0.73 | Why? |
| Mice, Inbred C57BL | 6 | 2020 | 5542 | 0.73 | Why? |
| Food Microbiology | 1 | 2019 | 114 | 0.71 | Why? |
| Nipah Virus | 1 | 2019 | 121 | 0.69 | Why? |
| Marburg Virus Disease | 1 | 2017 | 41 | 0.67 | Why? |
| Viral Vaccines | 8 | 2020 | 7560 | 0.67 | Why? |
| Mink | 1 | 2021 | 399 | 0.67 | Why? |
| Henipavirus Infections | 1 | 2019 | 122 | 0.67 | Why? |
| Human papillomavirus 16 | 1 | 2017 | 95 | 0.66 | Why? |
| Marburgvirus | 1 | 2017 | 71 | 0.66 | Why? |
| Madin Darby Canine Kidney Cells | 4 | 2020 | 640 | 0.65 | Why? |
| Mice | 20 | 2021 | 21357 | 0.65 | Why? |
| Antigens, Viral | 5 | 2021 | 6298 | 0.64 | Why? |
| Enzyme Assays | 1 | 2017 | 295 | 0.63 | Why? |
| Antibodies, Monoclonal | 8 | 2021 | 8041 | 0.62 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.62 | Why? |
| Mice, Inbred BALB C | 10 | 2021 | 5814 | 0.62 | Why? |
| Adenoviridae Infections | 1 | 2017 | 150 | 0.61 | Why? |
| Animals | 34 | 2021 | 78931 | 0.60 | Why? |
| Genetic Engineering | 1 | 2017 | 325 | 0.59 | Why? |
| Virus Physiological Phenomena | 1 | 2017 | 155 | 0.59 | Why? |
| HIV Seropositivity | 1 | 2017 | 320 | 0.58 | Why? |
| DEAD Box Protein 58 | 1 | 2017 | 250 | 0.58 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2017 | 349 | 0.57 | Why? |
| Amino Acid Substitution | 2 | 2019 | 1706 | 0.55 | Why? |
| Capsid Proteins | 1 | 2017 | 365 | 0.55 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 511 | 0.55 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.54 | Why? |
| HEK293 Cells | 11 | 2021 | 8394 | 0.51 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.51 | Why? |
| Antibodies, Viral | 17 | 2021 | 51949 | 0.49 | Why? |
| Guinea Pigs | 3 | 2019 | 420 | 0.49 | Why? |
| AIDS Vaccines | 1 | 2017 | 452 | 0.49 | Why? |
| Antibody Specificity | 1 | 2017 | 1328 | 0.49 | Why? |
| DNA | 1 | 2017 | 778 | 0.45 | Why? |
| Dogs | 4 | 2020 | 2529 | 0.44 | Why? |
| HIV Antibodies | 1 | 2017 | 776 | 0.44 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2018 | 1061 | 0.44 | Why? |
| Spike Glycoprotein, Coronavirus | 16 | 2021 | 37182 | 0.43 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.41 | Why? |
| Membrane Proteins | 2 | 2018 | 1733 | 0.41 | Why? |
| Plant Extracts | 1 | 2021 | 1514 | 0.41 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.39 | Why? |
| Swine Diseases | 1 | 2019 | 1219 | 0.38 | Why? |
| Luciferases, Firefly | 2 | 2017 | 20 | 0.36 | Why? |
| HIV-1 | 2 | 2017 | 3365 | 0.36 | Why? |
| Plasmids | 3 | 2020 | 840 | 0.34 | Why? |
| Staining and Labeling | 2 | 2017 | 169 | 0.32 | Why? |
| Swine | 3 | 2020 | 3352 | 0.31 | Why? |
| Genes, Reporter | 2 | 2017 | 472 | 0.30 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.30 | Why? |
| Rabbits | 2 | 2019 | 1171 | 0.29 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.29 | Why? |
| Cattle | 2 | 2020 | 1336 | 0.28 | Why? |
| Quinolizidines | 2 | 2021 | 14 | 0.28 | Why? |
| Piperidines | 2 | 2021 | 795 | 0.26 | Why? |
| Injections, Intramuscular | 3 | 2021 | 800 | 0.23 | Why? |
| Limit of Detection | 2 | 2020 | 2698 | 0.23 | Why? |
| Vaccines, DNA | 2 | 2019 | 871 | 0.22 | Why? |
| Cell Line | 5 | 2021 | 12040 | 0.22 | Why? |
| Seeds | 1 | 2021 | 114 | 0.22 | Why? |
| Virus Internalization | 4 | 2021 | 7921 | 0.22 | Why? |
| Binding Sites | 7 | 2021 | 6201 | 0.22 | Why? |
| Tropism | 1 | 2021 | 210 | 0.20 | Why? |
| Occupational Exposure | 1 | 2019 | 4742 | 0.20 | Why? |
| RAW 264.7 Cells | 1 | 2020 | 316 | 0.20 | Why? |
| HeLa Cells | 2 | 2020 | 1303 | 0.20 | Why? |
| Stomach | 1 | 2020 | 141 | 0.20 | Why? |
| SARS Virus | 6 | 2020 | 13021 | 0.19 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.19 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.19 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.19 | Why? |
| Endonucleases | 1 | 2018 | 68 | 0.18 | Why? |
| Cricetinae | 3 | 2021 | 3344 | 0.18 | Why? |
| Drug Administration Routes | 1 | 2018 | 106 | 0.18 | Why? |
| Vesicular stomatitis Indiana virus | 1 | 2020 | 354 | 0.18 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2018 | 191 | 0.18 | Why? |
| Feedback, Physiological | 1 | 2017 | 56 | 0.18 | Why? |
| Blood | 1 | 2019 | 274 | 0.17 | Why? |
| Autophagy-Related Protein-1 Homolog | 1 | 2017 | 32 | 0.17 | Why? |
| Mutagenesis, Site-Directed | 1 | 2019 | 449 | 0.17 | Why? |
| Filoviridae | 1 | 2018 | 70 | 0.17 | Why? |
| Cathepsin L | 1 | 2021 | 566 | 0.17 | Why? |
| Escherichia coli Proteins | 1 | 2018 | 168 | 0.17 | Why? |
| Milk | 1 | 2018 | 158 | 0.17 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.17 | Why? |
| Lassa virus | 1 | 2017 | 99 | 0.17 | Why? |
| Farms | 1 | 2018 | 269 | 0.16 | Why? |
| China | 7 | 2021 | 50654 | 0.16 | Why? |
| Neuraminidase | 1 | 2019 | 289 | 0.16 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2018 | 8843 | 0.16 | Why? |
| Membrane Glycoproteins | 2 | 2020 | 2273 | 0.15 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2017 | 249 | 0.15 | Why? |
| Humans | 40 | 2021 | 930598 | 0.15 | Why? |
| Colistin | 1 | 2018 | 217 | 0.15 | Why? |
| Glycosylation | 1 | 2020 | 1255 | 0.15 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.15 | Why? |
| Nucleocapsid Proteins | 2 | 2007 | 3120 | 0.15 | Why? |
| Vero Cells | 6 | 2021 | 14117 | 0.15 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.15 | Why? |
| Trachea | 1 | 2020 | 894 | 0.14 | Why? |
| Chemokine CCL2 | 1 | 2017 | 389 | 0.14 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 334 | 0.14 | Why? |
| Genotyping Techniques | 1 | 2017 | 360 | 0.14 | Why? |
| Biological Assay | 1 | 2017 | 367 | 0.14 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.14 | Why? |
| Virus Assembly | 1 | 2017 | 438 | 0.14 | Why? |
| Epidemiologic Studies | 1 | 2017 | 554 | 0.14 | Why? |
| Primates | 1 | 2017 | 584 | 0.14 | Why? |
| Sensitivity and Specificity | 7 | 2020 | 22971 | 0.14 | Why? |
| Cysteine Proteinase Inhibitors | 1 | 2021 | 675 | 0.13 | Why? |
| A549 Cells | 1 | 2020 | 2066 | 0.13 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.13 | Why? |
| Receptors, Virus | 2 | 2021 | 5659 | 0.13 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 624 | 0.13 | Why? |
| Nose | 1 | 2020 | 1093 | 0.13 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.13 | Why? |
| Vaccines, Inactivated | 1 | 2021 | 1562 | 0.13 | Why? |
| Proteolysis | 1 | 2017 | 751 | 0.13 | Why? |
| Macaca mulatta | 2 | 2020 | 3716 | 0.13 | Why? |
| Receptors, Immunologic | 1 | 2017 | 555 | 0.13 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.13 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.12 | Why? |
| Virology | 1 | 2017 | 489 | 0.12 | Why? |
| Containment of Biohazards | 1 | 2019 | 762 | 0.12 | Why? |
| Prevalence | 3 | 2019 | 25773 | 0.12 | Why? |
| Antibodies | 1 | 2019 | 846 | 0.12 | Why? |
| Female | 19 | 2021 | 380317 | 0.12 | Why? |
| Papillomavirus Vaccines | 1 | 2017 | 405 | 0.12 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.12 | Why? |
| Seroepidemiologic Studies | 2 | 2019 | 10017 | 0.12 | Why? |
| RNA, Viral | 4 | 2020 | 32276 | 0.11 | Why? |
| Recombination, Genetic | 1 | 2018 | 1265 | 0.11 | Why? |
| Orthomyxoviridae Infections | 1 | 2019 | 1001 | 0.11 | Why? |
| Immunoglobulin M | 3 | 2019 | 9091 | 0.11 | Why? |
| Interferon-beta | 1 | 2017 | 979 | 0.11 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.11 | Why? |
| CRISPR-Cas Systems | 1 | 2020 | 1397 | 0.11 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.10 | Why? |
| Reference Standards | 2 | 2021 | 1163 | 0.10 | Why? |
| Cathepsin B | 2 | 2021 | 101 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.10 | Why? |
| Rats | 1 | 2017 | 2764 | 0.10 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.10 | Why? |
| Antigen-Antibody Reactions | 2 | 2021 | 616 | 0.10 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.09 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.09 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Structure-Activity Relationship | 3 | 2021 | 2219 | 0.09 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.09 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.09 | Why? |
| Protein Domains | 4 | 2021 | 6563 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2020 | 3231 | 0.08 | Why? |
| Virus Replication | 2 | 2020 | 14331 | 0.08 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.08 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Protein Conformation | 1 | 2017 | 4386 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Macaca fascicularis | 2 | 2021 | 1009 | 0.08 | Why? |
| RNA, Messenger | 1 | 2020 | 5131 | 0.08 | Why? |
| Hybridomas | 1 | 2004 | 74 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.07 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.07 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.07 | Why? |
| Liver | 1 | 2019 | 4007 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.07 | Why? |
| Aging | 1 | 2020 | 3581 | 0.07 | Why? |
| Molecular Dynamics Simulation | 3 | 2021 | 4155 | 0.06 | Why? |
| Viral Proteins | 2 | 2017 | 7370 | 0.06 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| Crystallography, X-Ray | 2 | 2021 | 2689 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Cryoelectron Microscopy | 2 | 2021 | 2372 | 0.06 | Why? |
| Brain | 1 | 2020 | 5133 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.06 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2008 | 952 | 0.06 | Why? |
| Pan troglodytes | 1 | 2021 | 157 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.06 | Why? |
| Severe Acute Respiratory Syndrome | 4 | 2007 | 12361 | 0.06 | Why? |
| Genes, Viral | 1 | 2007 | 1428 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2021 | 2886 | 0.05 | Why? |
| Haplorhini | 1 | 2021 | 307 | 0.05 | Why? |
| Receptors, CXCR3 | 1 | 2020 | 159 | 0.05 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.05 | Why? |
| Mice, Inbred ICR | 1 | 2020 | 242 | 0.05 | Why? |
| Immunoglobulin G | 3 | 2019 | 21571 | 0.05 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.05 | Why? |
| Clone Cells | 1 | 2020 | 312 | 0.05 | Why? |
| Hepatitis B | 1 | 2008 | 888 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 11367 | 0.05 | Why? |
| Crystallization | 1 | 2020 | 331 | 0.05 | Why? |
| Surface Plasmon Resonance | 1 | 2021 | 440 | 0.05 | Why? |
| Protein Structure, Quaternary | 1 | 2020 | 455 | 0.05 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.05 | Why? |
| Vaccine Potency | 1 | 2020 | 339 | 0.05 | Why? |
| Cross Reactions | 2 | 2020 | 4374 | 0.05 | Why? |
| Chlorobenzenes | 1 | 2018 | 35 | 0.05 | Why? |
| Serum | 1 | 2020 | 294 | 0.05 | Why? |
| Base Sequence | 1 | 2007 | 3581 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Rats, Sprague-Dawley | 1 | 2021 | 987 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Models, Animal | 1 | 2020 | 788 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2021 | 1132 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.04 | Why? |
| Lung | 3 | 2020 | 31049 | 0.04 | Why? |
| Virus Activation | 1 | 2021 | 480 | 0.04 | Why? |
| Hepatitis C | 1 | 2008 | 1514 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 7868 | 0.04 | Why? |
| DNA, Viral | 1 | 2007 | 2521 | 0.04 | Why? |
| Spleen | 1 | 2020 | 877 | 0.04 | Why? |
| Molecular Structure | 1 | 2021 | 1539 | 0.04 | Why? |
| Epitope Mapping | 1 | 2020 | 1240 | 0.04 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.04 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.04 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.04 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.03 | Why? |
| Proteome | 1 | 2004 | 1812 | 0.03 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2004 | 2149 | 0.03 | Why? |
| Catalytic Domain | 1 | 2018 | 1757 | 0.03 | Why? |
| Molecular Diagnostic Techniques | 1 | 2008 | 4239 | 0.03 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.02 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.02 | Why? |
| Nanoparticles | 1 | 2020 | 2040 | 0.02 | Why? |
| Adult | 4 | 2021 | 244371 | 0.02 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.02 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2004 | 393 | 0.02 | Why? |
| Decision Trees | 1 | 2004 | 441 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2018 | 6902 | 0.02 | Why? |
| Protein Array Analysis | 1 | 2004 | 387 | 0.01 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 449 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Blood Specimen Collection | 1 | 2004 | 387 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Algorithms | 1 | 2004 | 7346 | 0.01 | Why? |
| Biomarkers | 1 | 2004 | 23361 | 0.00 | Why? |
| Retrospective Studies | 1 | 2004 | 105322 | 0.00 | Why? |